title: Termination of the CRESCENDO trial.
authors.forename: Dominique
authors.initials: D
authors.lastname: Roberfroid
authors.forename: Carl
authors.initials: C
authors.lastname: Lachat
authors.forename: Catherine
authors.initials: C
authors.lastname: Lucet
mesh_terms: D019440:Anti-Obesity Agents / Q000009:adverse effects; D002317:Cardiovascular Agents / Q000008:administration & dosage / Q000009:adverse effects*; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D003866:Depressive Disorder / Q000150:complications / Q000453:epidemiology; D017277:Drug Approval; D005060:Europe; D006801:Humans; D015337:Multicenter Studies as Topic; D010880:Piperidines / Q000008:administration & dosage / Q000009:adverse effects*; D011720:Pyrazoles / Q000008:administration & dosage / Q000009:adverse effects*; D016032:Randomized Controlled Trials as Topic; D000077285:Rimonabant; D013405:Suicide / Q000523:psychology / Q000706:statistics & numerical data*; D017211:Treatment Failure
chemical_list: D019440:Anti-Obesity Agents; D002317:Cardiovascular Agents; D010880:Piperidines; D011720:Pyrazoles; D000077285:Rimonabant